How do we decide how representative our donors are for public health surveillance?
- PMID: 36193865
- DOI: 10.1111/trf.17140
How do we decide how representative our donors are for public health surveillance?
Abstract
Background: Surveillance of blood donors is fundamental to safety of the blood supply. Such data can also be useful for public health policy but tend to be underutilized. When the COVID-19 pandemic arrived, blood centers around the world measured blood donor SARS-CoV-2 seroprevalence to inform public health policy. There is now a movement toward blood centers becoming more involved in public health research and surveillance post-pandemic. However, blood donors are a healthy population and not representative of all segments of the general population. In this article, we explain how blood centers can evaluate their donor base to understand which part of the general population they are representative of.
Study design and methods: Methodologic approaches for evaluating samples relative to the target population were reviewed. Blood donor data that are available to most blood centers were identified and application to assess representativeness of blood donors was evaluated.
Results: Key aspects of blood donor data to compare with general population data include donor selection criteria, health indicators, geography, and demographics. In some cases, statistical adjustment can improve representativeness.
Discussion: Comparing key blood donor data with corresponding general population data can define the subset of the general population for which a particular blood center's donors may be representative of. We suggest that donors are an ideal convenience population for surveillance of infectious agents which are frequently asymptomatic and main routes of transmission are not deferrable, for studying the natural history of disease in an initially well population, and for vaccination serology surveillance.
Keywords: blood donors; public health; surveillance.
© 2022 AABB.
References
REFERENCES
-
- Betsem E, Kaidarova Z, Stramer SL, Shaz B, Sayers M, LeParc G, et al. Correlation of West Nile Virus incidence in donated blood with West Nile neuroinvasive disease rates, United States, 2021-2012. Emerg Infect Dis. 2017;23:212-9.
-
- Zhao J, Rostgaard K, Hjalgrim H, Edgren G. The Swedish Scandinavian donations and transfusions database (SCANDAT3-S) - 50 years of donor and recipient follow-up. Transfusion. 2020;60:3019-27.
-
- Pedersen OB, Erikstrup C, Kotzé SR, Sorensen E, Petersen MS, Grau K, et al. The Danish blood donor study: a large, prospective cohort and biobank for medical research. Vox Sang. 2012;102:271.
-
- O'Brien SF, Lieshout-Krikke R, Lewin A, Erikstrup C, Steele WR, Uzicanin S, et al. Research initiatives of blood services worldwide in response to the COVID-19 pandemic. Vox Sang. 2021;116:296-304.
-
- Jones JM, Stone M, Sulaeman H, Fink RV, Dave H, Levy ME, et al. Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021. JAMA. 2021;326:1400-9.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous